Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adherium Ltd. ( (AU:ADR) ) just unveiled an announcement.
Adherium Limited announced a delay in lodging the Appendix 3H with the ASX due to an administrative oversight, which the company views as an isolated incident. Despite this, Adherium maintains confidence in its compliance practices with ASX Listing Rules, suggesting minimal impact on its operations or stakeholder relations.
More about Adherium Ltd.
Adherium is a leading digital health company specializing in integrated digital health solutions and connected respiratory medical devices. With over 180,000 devices sold globally, the company offers the Hailie® platform, which allows clinicians, healthcare providers, and patients to monitor medication usage and adherence remotely. The platform includes tools for data integration and sharing, enhancing the management of respiratory diseases.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.98M
Learn more about ADR stock on TipRanks’ Stock Analysis page.